London Co. of Virginia Makes New Investment in Avantor, Inc. $AVTR

London Co. of Virginia purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 12,793,957 shares of the company’s stock, valued at approximately $159,669,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of AVTR. TD Private Client Wealth LLC raised its position in Avantor by 9.2% in the third quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock worth $100,000 after acquiring an additional 670 shares in the last quarter. TD Waterhouse Canada Inc. raised its holdings in shares of Avantor by 2.5% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 38,977 shares of the company’s stock worth $532,000 after purchasing an additional 966 shares in the last quarter. SG Americas Securities LLC lifted its stake in Avantor by 2.7% during the second quarter. SG Americas Securities LLC now owns 37,078 shares of the company’s stock valued at $499,000 after purchasing an additional 979 shares during the last quarter. Evergreen Capital Management LLC lifted its stake in Avantor by 7.7% during the third quarter. Evergreen Capital Management LLC now owns 14,347 shares of the company’s stock valued at $179,000 after purchasing an additional 1,026 shares during the last quarter. Finally, Osaic Holdings Inc. boosted its holdings in Avantor by 60.9% during the second quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Down 4.1%

AVTR stock opened at $7.61 on Tuesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.18. The firm has a market capitalization of $5.19 billion, a P/E ratio of -9.75, a P/E/G ratio of 3.11 and a beta of 0.97. Avantor, Inc. has a 52-week low of $7.57 and a 52-week high of $17.11. The company’s 50 day simple moving average is $10.28 and its 200-day simple moving average is $11.63.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the business posted $0.27 EPS. The company’s revenue was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, equities research analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Activity

In other Avantor news, Director Gregory L. Summe bought 100,000 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was acquired at an average price of $9.40 per share, with a total value of $940,000.00. Following the completion of the transaction, the director directly owned 400,000 shares in the company, valued at approximately $3,760,000. This represents a 33.33% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Sanjeev K. Mehra purchased 125,000 shares of the stock in a transaction dated Tuesday, March 10th. The shares were acquired at an average price of $8.01 per share, for a total transaction of $1,001,250.00. Following the acquisition, the director directly owned 475,000 shares of the company’s stock, valued at $3,804,750. This represents a 35.71% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 275,000 shares of company stock worth $2,399,250 over the last quarter. Corporate insiders own 1.20% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on AVTR. Evercore set a $10.00 price target on Avantor in a report on Wednesday, February 11th. Stifel Nicolaus set a $10.00 price objective on Avantor in a research note on Thursday, February 12th. Jefferies Financial Group restated an “underperform” rating and issued a $8.00 target price on shares of Avantor in a report on Thursday, February 12th. Barclays reaffirmed an “underweight” rating and set a $8.50 target price on shares of Avantor in a research report on Friday, March 6th. Finally, TD Cowen reaffirmed a “hold” rating on shares of Avantor in a report on Thursday, February 12th. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Avantor has an average rating of “Hold” and an average price target of $11.80.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.